176721-01-0

176721-01-0 structure

Name	α-(2,3-Dimethylphenyl)-1-(trityl)-1H-imidazole-4-methanol
Synonyms	alpha-(2,3-Dimethylphenyl)-1-(trityl)-1H-imidazole-4-methanol 1H-IMidazole-4-Methanol, α-(2,3-diMethylphenyl)-1-(triphenylMethyl) 1-(2,3-dimethylphenyl)-1-(1H-imidazol-4-triphenylmethyl)methanol alpha-(2,3-Dimethylphenyl)-1-(trityl)-1H-imidazole-4-methano α-(2,3-Dimethylphenyl)-1-(trityl)-1H-imidazole-4-methan (2,3-dimethylphenyl)-(3-tritylimidazol-4-yl)methanol (2,3-diMethylphenyl)(1-trityl-1H-iMidazol-4-yl)Methanol (2,3-Dimethylphenyl)-(3-trityl-3H-imidazol-4-yl)methanol α-(2,3-Dimethylphenyl)-1-(triphenylmethyl)-1H-imidazole-4-methanol alpha-(2,3-Dimethylphenyl)-1-(triphenylmethyl)-1H-imidazol-4-methanol Dexmedetomidine Impurity 28 (2,3-Dimethylphenyl)(1-trityl-1H-imidazol-5-yl)methanol

5779-93-1

96797-15-8

~84%

176721-01-0

Literature: "Joint Stock Company Grindeks" Patent: EP1918282 A1, 2008 ; Location in patent: Page/Page column 5 ;

576-23-8

33016-47-6

176721-01-0

Literature: Cordi, Alex A.; Persigand, Thierry; Lecouve, Jean-Pierre Synthetic Communications, 1996 , vol. 26, # 8 p. 1585 - 1593